2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Saturday, June 11, 2016

5:30pm-7:30pm: Transitional B Cell T1/T2 Ratio Is a Prognostic Marker for Human Renal Allograft Deterioration.

A. Cherukuri,¹ D. Rothstein,¹ R. Baker.²

Poster Session A: Kidney: Acute Cellular Rejection • Halls C&D

5:30pm-7:30pm: Transplantation for Hepatocellularcarcinoma Is There a Tumor Size Limit?

A. Daoud, L. Teeter, M. Ghobrial, E. Graviss, S. Mogawer, A. Sholkamy, M. Alshazly, H. Monsour, A. Gaber.

Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies • Halls C&D

5:30pm-7:30pm: United States versus Australia: Is "Percentage Decline in Estimated Glomerular Filtration Rate" Truly a Surrogate Outcome in Graft Survival?

K. Parker,² A. Rice,¹ A. Kirby,¹ M. Pinion,¹ K. Parker.²

Poster Session A: Poster Session III: Kidney Complications-Other • Halls C&D

5:30pm-7:30pm: Updated Experience of Living Donor Right Hepatectomy Using Mini-Incision Technique.

S. Nagai, A. Yoshida, M. Rizzari, K. Collins, D. Kim, M. Abouljoud.

Poster Session A: Living Donor Liver Transplantation • Halls C&D

5:30pm-7:30pm: Urinary Exosomal Annexin A1 Is a Predictive Biomarker of Post Kidney Transplant Complications.

H. Harada,¹ T. Murakami,² C. Yamamoto,² K. Hotta,¹ N. Fukuzawa,¹ M. Mitsuhashi.²

Poster Session A: Kidney: Acute Cellular Rejection • Halls C&D

5:30pm-7:30pm: Urinary Expression of miRNA-155, miRNA-210, miRNA-142 and CXCL-10 Production Predicts the Risk of Acute Rejection and Graft Outcome in Renal Transplant Recipients.

O. Millan,¹ K. Budde,² C. Sommerer,³ I. Aliart,¹ O. Rissling,² B. Bardaji,⁴ M. Matz,² M. Zeier,³ I. Silva,⁴ L. Guirado,⁴ M. Brunet.¹

Poster Session A: Kidney: Acute Cellular Rejection • Halls C&D

5:30pm-7:30pm: Urinary Markers of Proximal Tubular Dysfunction in Kidney Transplant as Predictors for CKD.

P. Garcia, V. Garcia-Nieto, J. Navarro, E. Martin, A. Rivero, A. Jarque, J. Gonzalez-Posadas, M. Macia.

Poster Session A: Poster Session III: Kidney Complications-Other • Halls C&D

5:30pm-7:30pm: Urine-Derived Cell Lines as a Novel Tool for Monitoring Allo-Reactivity in Kidney Transplant Patients.

C. Thieme,¹ B. Weist,¹ M. Schmück,¹ P. Reinke,¹ N. Babel.^1,2

Poster Session A: Kidney: Acute Cellular Rejection • Halls C&D

5:30pm-7:30pm: Use of Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma Does Not Increase Recurrence.

A. Gupta, M. Ramsay, G. Saracino, T. Anthony, R. Goldstein, G. McKenna, N. Onaca, R. Ruiz, G. Klintmalm, P. Kim.

Poster Session A: Liver - Hepatocellular Carcinoma and Cholangiocarcinoma Malignancies • Halls C&D

5:30pm-7:30pm: Use of Integrated National Registry and Pharmacy Claims Data to Identify Diabetes Mellitus After Live Pancreas Donation.

K. Lentine,^1,7 N. Lam,² H. Randall,⁸ D. Axelrod,³ D. Segev,^4,1 G. Hess,⁵ A. Garg,⁶ D. Brennan,⁷ B. Kasiske,⁸ M. Schnitzler.^8,1

Poster Session A: Clinical Pancreas Transplantation and All Islet Cell Transplantation Topics • Halls C&D